The Filgrastim Injection, cataloged under National Stock Number 6505-01-654-2274, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amgen Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-654-2274 |
| Primary Part Number | NDC55513-0530-10 |
| Item Name | Filgrastim Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amgen Inc. |
| Status | ACTIVE |
| Administration | INTRAVENOUS AND SUBCUTANEOUS |
| Primary Container Content Quantity | 1.60 MILLILITERS |
| Features Provided | STERILE |
| Primary Container Type | VIAL, SINGLE DOSE |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| Active Medicament Medicinal Strength | 300.0 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC55513-0530-10 PRIMARY | Amgen Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM162737 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1402465 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-654-2274 is a Filgrastim Injection, manufactured by Amgen Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-654-2274 has 1 manufacturer part number on file: NDC55513-0530-10 (Amgen Inc.).
Key specifications for NDC55513-0530-10: Administration: INTRAVENOUS AND SUBCUTANEOUS; Primary Container Content Quantity: 1.60 MILLILITERS; Features Provided: STERILE; Primary Container Type: VIAL, SINGLE DOSE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.